Driven by Discovery, Inspired by Community

For Dr. Arnold Kristof, supporting the LAM community has been a 26-year journey shaped by mentorship, collaboration, and a commitment to advancing new treatment options for women living with LAM.

His connection to the field began with research mentor Joel Moss, who influenced his dedication to LAM research. Over the years, The LAM Foundation has played an important role in supporting his work, connecting him with patients and colleagues, and creating opportunities for scientific discovery.

“Patients are often referred to me via The LAM Foundation,” Arnold shares. He also participates in the LAM Clinic Network, attends LAMposium, and values the opportunity to learn from patients, Foundation staff, and fellow scientists.

“I benefit from advice from colleagues in the community and the LAM Foundation website,” he explains. “The LAM Foundation helps me advocate for LAM patients and scientific advancement via the Scientific Advisory Board.”

The LAM Foundation has also been an important source of research funding throughout Arnold’s career. Early on, he received an Established Investigator Award, which helped build the foundation for sustained funding from the National Institutes of Health (NIH) and the Canadian Institutes of Health Research (CIHR) for his work on mTOR signaling.

More recently, a LAM Foundation Pilot Feasibility Award supported preliminary research for a new project exploring potential therapies for LAM.

This work targets cancer-like processes that are not sensitive to rapamycin, with the goal of identifying new treatment approaches for patients who may need options beyond existing therapies.

“The LAM Foundation has provided critical funding for my research,” Arnold says.

Equally meaningful have been the direct interactions with women living with LAM.

“I have had several organized or informal collaborative (and inspiring) interactions with LAM patients at LAMposium over the years,” he recalls.

One experience stands out: a design-thinking exercise at the 2017 Patient Benefit Conference. Bringing patients and researchers together to share perspectives offered an opportunity to think differently about challenges and possibilities in LAM research.

“Work with The LAM Foundation has enlightened me regarding issues surrounding women’s health in LAM and in rare diseases.”

After 26 years, Arnold’s work reflects the importance of connecting researchers, clinicians, and patients to move discoveries forward, and bring us closer to better treatments for everyone living with LAM.


Support compassionate care